Market Study on Viral Vector Vaccines: Close to Two-thirds of Vaccines Administered to Adults

Publish Date: May 2023

Report Code: PMR2455A

Publisher: Persistence Market Research

Single User License: $4900

Explore Our Services

Already a member? Login here.

Report Highlights

Viral Vector Vaccines Market: Report Scope

The latest publication by Persistence Market Research on the global viral vector vaccines market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 to 2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for viral vector vaccines and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the viral vector vaccines market. Shareholders in the viral vector vaccines market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the viral vector vaccines market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the viral vector vaccines market offers information divided into three important segments - patient, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Attribute Details

Patient

  • Paediatric
  • Adults

Distribution Channel

  • Hospitals
  • Government Institutes

Region

  • North America
  • Europe
  • East Asia
  • Middle East and Africa (MEA)

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets viral vector vaccines over the coming years?
  • How will changing trends influence the market?
  • How has the COVID-19 crisis influenced market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will influence the market?
  • How can companies in the viral vector vaccines market avail themselves of the growth opportunities in developed and emerging sectors?

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2023-2033
Units considered $ Million
Segments covered By Patient, By Distribution Channel by Region, by Country
Industry covered Healthcare
Countries covered North America, Europe, East Asia, Middle East & Africa
Companies studied
  • Merck & Co., Inc.
  • Johnson & Johnson ( Janssen Global Services, LLC)

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the viral vector vaccines market and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the viral vector vaccines market are more accurate and reliable.

  • Table 1 : Global Viral Vector Vaccines Market Analysis 2017-2022 and Forecast 2023-2033 By Patient
  • Table 2 : Global Viral Vector Vaccines Market Analysis 2017-2022 and Forecast 2023-2033By Distribution Channel
  • Table 3 : Global Viral Vector Vaccines Market Analysis 2017-2022 and Forecast 2023-2033 by Region
  • Table 4 : North America Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 by Country
  • Table 5 : North America Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 By Patient
  • Table 6 : North America Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 By Distribution Channel
  • Table 7 : Europe Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 by Country
  • Table 8 : Europe Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 By Patient
  • Table 9 : Europe Viral Vector Vaccines Market Analysis 2017-2022 and Forecast 2023-2033By Distribution Channel
  • Table 10 : East Asia Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 by Country
  • Table 11 : East Asia Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 By Patient
  • Table 12 : East Asia Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 By Distribution Channel
  • Table 13 : Middle East & Africa Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 by Country
  • Table 14 : Middle East & Africa Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022 and Forecast 2023-2033 By Patient
  • Table 15 : Middle East & Africa Viral Vector Vaccines Market Analysis 2017-2022 and Forecast 2023-2033 By Distribution Channel
  • Figure 1 : Global Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022
  • Figure 2 : Global Viral Vector Vaccines Market Forecast & Y-o-Y Growth 2023-2033
  • Figure 3 : Global Viral Vector Vaccines Market Absolute $ Opportunity (US$ Mn) Analysis 2022-2033
  • Figure 4 : Global Viral Vector Vaccines Market Value Share (%) Analysis 2023 and 2033 By Patient
  • Figure 5 : Global Viral Vector Vaccines Market Y-o-Y Growth (%) Analysis 2022-2033 By Patient
  • Figure 6 : Global Viral Vector Vaccines Market Attractiveness Analysis 2023-2033 By Patient
  • Figure 7 : Global Viral Vector Vaccines Market Value Share (%) Analysis 2023 and 2033 By Distribution Channel
  • Figure 8 : Global Viral Vector Vaccines Market Y-o-Y Growth (%) Analysis 2022-2033 By Distribution Channel
  • Figure 9 : Global Viral Vector Vaccines Market Attractiveness Analysis 2023-2033 By Distribution Channel
  • Figure 10 : Global Viral Vector Vaccines Market Value Share (%) Analysis 2023 and 2033 by Region
  • Figure 11 : Global Viral Vector Vaccines Market Y-o-Y Growth (%) Analysis 2022-2033 by Region
  • Figure 12 : Global Viral Vector Vaccines Market Attractiveness Analysis 2023-2033 by Region
  • Figure 13 : North America Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022
  • Figure 14 : North America Viral Vector Vaccines Market Value (US$ Mn) Forecast 2023-2033
  • Figure 15 : North America Viral Vector Vaccines Market Value Share By Patient (2023 E)
  • Figure 16 : North America Viral Vector Vaccines Market Value Share By Distribution Channel (2023 E)
  • Figure 17 : North America Viral Vector Vaccines Market Value Share by Country (2023 E)
  • Figure 18 : North America Viral Vector Vaccines Market Attractiveness Analysis By Patient 2023-2033
  • Figure 19 : North America Viral Vector Vaccines Market Attractiveness Analysis by Country 2023-2033
  • Figure 20 : U.S. Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 21 : Global Vs. U.S. Growth Comparison 2022 - 2033
  • Figure 22 : U.S. Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 23 : U.S. Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 24 : Canada Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 25 : Global Vs. Canada. Growth Comparison 2022 - 2033
  • Figure 26 : Canada Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 27 : Canada Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 28 : Europe Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022
  • Figure 29 : Europe Viral Vector Vaccines Market Value (US$ Mn) Forecast 2023-2033
  • Figure 30 : Europe Viral Vector Vaccines Market Value Share By Patient (2023 E)
  • Figure 31 : Europe Viral Vector Vaccines Market Value Share By Distribution Channel (2023 E)
  • Figure 32 : Europe Viral Vector Vaccines Market Value Share by Country (2023 E)
  • Figure 33 : Europe Viral Vector Vaccines Market Attractiveness Analysis By Patient 2023-2033
  • Figure 34 : Europe Viral Vector Vaccines Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 35 : Europe Viral Vector Vaccines Market Attractiveness Analysis by Country 2023-2033
  • Figure 36 : Germany Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 37 : Global Vs. Germany Growth Comparison 2022 - 2033
  • Figure 38 : Germany Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 39 : Germany Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 40 : France Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 41 : Global Vs France Growth Comparison 2022 - 2033
  • Figure 42 : France Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 43 : France Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 44 : U.K. Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 45 : Global Vs. U.K. Growth Comparison 2022 - 2033
  • Figure 46 : U.K. Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 47 : U.K. Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 48 : Italy Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 49 : Global Vs. Italy Growth Comparison 2022 - 2033
  • Figure 50 : Italy Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 51 : Italy Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 52 : Spain Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 53 : Global Vs Spain Growth Comparison 2022 - 2033
  • Figure 54 : Spain Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 55 : Spain Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 56 : Russia Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 57 : Global Vs Russia Growth Comparison 2022 - 2033
  • Figure 58 : Russia Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 59 : Russia Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 60 : BENELUX Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 61 : Global Vs BENELUX Growth Comparison 2022 - 2033
  • Figure 62 : BENELUX Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 63 : BENELUX Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 64 : Nordic Countries Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 65 : Global Vs Nordic Countries Growth Comparison 2022 - 2033
  • Figure 66 : Nordic Countries Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 67 : Nordic Countries Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 68 : East Asia Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022
  • Figure 69 : East Asia Viral Vector Vaccines Market Value (US$ Mn) Forecast 2023-2033
  • Figure 70 : East Asia Viral Vector Vaccines Market Value Share By Patient (2023 E)
  • Figure 71 : East Asia Viral Vector Vaccines Market Value Share By Distribution Channel (2023 E)
  • Figure 72 : East Asia Viral Vector Vaccines Market Value Share by Country (2023 E)
  • Figure 73 : East Asia Viral Vector Vaccines Market Attractiveness Analysis By Patient 2023-2033
  • Figure 74 : East Asia Viral Vector Vaccines Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 75 : East Asia Viral Vector Vaccines Market Attractiveness Analysis by Country 2023-2033
  • Figure 76 : China Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 77 : Global Vs. China Growth Comparison 2022 - 2033
  • Figure 78 : China Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 79 : China Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 80 : Japan Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 81 : Global Vs. Japan Growth Comparison 2022 - 2033
  • Figure 82 : Japan Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 83 : Japan Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 84 : South Korea Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 85 : Global Vs South Korea Growth Comparison 2022 - 2033
  • Figure 86 : South Korea Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 87 : South Korea Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 88 : Middle East & Africa Viral Vector Vaccines Market Value (US$ Mn) Analysis 2017-2022
  • Figure 89 : Middle East & Africa Viral Vector Vaccines Market Value (US$ Mn) Forecast 2023-2033
  • Figure 90 : Middle East & Africa Viral Vector Vaccines Market Value Share By Patient (2023 E)
  • Figure 91 : Middle East & Africa Viral Vector Vaccines Market Value Share By Distribution Channel (2023 E)
  • Figure 92 : Middle East & Africa Viral Vector Vaccines Market Value Share by Country (2023 E)
  • Figure 93 : Middle East & Africa Viral Vector Vaccines Market Attractiveness Analysis By Patient 2023-2033
  • Figure 94 : Middle East & Africa Viral Vector Vaccines Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 95 : Middle East & Africa Viral Vector Vaccines Market Attractiveness Analysis by Country 2023-2033
  • Figure 96 : Turkiye Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 97 : Global Vs. Turkiye Growth Comparison 2022 - 2033
  • Figure 98 : Turkiye Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 99 : Turkiye Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 100 : GCC Countries Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 101 : Global Vs GCC Countries Growth Comparison 2022 - 2033
  • Figure 102 : GCC Countries Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 103 : GCC Countries Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 104 : North Africa Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 105 : Global Vs North Africa Growth Comparison 2022 - 2033
  • Figure 106 : North Africa Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 107 : North Africa Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 108 : South Africa Viral Vector Vaccines Market Value Proportion Analysis 2022
  • Figure 109 : Global Vs. South Africa Growth Comparison 2022 - 2033
  • Figure 110 : South Africa Viral Vector Vaccines Market Share Analysis (%) By Patient 2022 & 2033
  • Figure 111 : South Africa Viral Vector Vaccines Market Share Analysis (%) By Distribution Channel 2022 & 2033

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Market Study on Viral Vector Vaccines: Close to Two-thirds of Vaccines Administered to Adults